After Novartis had obtained a preliminary injunction against Pharmathen, it observed that there were still infringing acts being performed. In the first instance, the provisions judge sided with Novartis and ordered that Pharmathen had to pay EUR 7,500,000 as a penalty. On appeal Pharmathen tried to reverse this verdict, but its efforts were in vain.
Case date: 26 March 2024
Casa number: 200.321.764/01
Court: Court of Appeal of Amsterdam
A full summary of this case has been published on Kluwer IP Law
________________________
To make sure you do not miss out on regular updates from the Kluwer Patent Blog, please subscribe here.
